<PAGE>
                                UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                  FORM 10-KSB

[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
                                  For the Fiscal Year Ended December 31, 2005

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
                                For the transition period from _____ to _____

                                                Commission File No. 000-27836

                              ORTHODONTIX, INC.
-----------------------------------------------------------------------------
             (Name of small business issuer in its charter)

             FLORIDA                                     65-0643773
---------------------------------           ---------------------------------
(State or other jurisdiction of             (IRS Employer Identification No.)
incorporation or organization)

 1428 Brickell Avenue, Suite 105
      Miami, Florida                                      33131
----------------------------------------    ---------------------------------
(Address of principal executive offices)                (Zip Code)

Issuer's Telephone Number (305) 371-4112
                          ------------------------------

Securities registered under Section 12(b) of the Exchange Act: None.

      Title of each class           Name of each exchange on which registered

----------------------------        -----------------------------------------

Securities registered under Section 12(g) of the Exchange Act:

                 Common Stock, par value $.0001 per share
-----------------------------------------------------------------------------
                              (Title of class)

-----------------------------------------------------------------------------
                              (Title of class)

Check whether the issuer is not required to file reports pursuant to Section
13 or 15(d) of the Exchange Act. [ ]






<PAGE>
     Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
                                                               Yes [X] No [ ]

     Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-
KSB or any amendment to this Form 10-KSB.                                 [X]

     Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act.                     Yes [X] No [ ]

     State issuer's revenues for its most recent fiscal year:  $0.

     The aggregate market value of the voting and non-voting common equity
held by non-affiliates of the Company based on the average of the bid and
asked price of $3.695 of such Common Stock, as of March 27, 2006, is
$9,167,764.

     As of March 27, 2006, the Company had a total of 5,830,856 shares of
Common Stock, par value $.0001 per share, outstanding.

                 DOCUMENTS INCORPORATED BY REFERENCE:  None.






























<PAGE>
                              ORTHODONTIX, INC.
                                FORM 10-KSB
                     FISCAL YEAR ENDED DECEMBER 31, 2005
<TABLE>
<CAPTION>
TABLE OF CONTENTS                                               Page
                                                                ----
<S>                                                              <C>
PART I                                                           -1-
   Item 1.     Description of Business                           -1-

   Item 2.     Description of Property                           -2-

   Item 3.     Legal Proceedings                                 -2-

   Item 4.     Submission of Matters to a Vote
               of Security Holders                               -2-

PART II                                                          -2-
   Item 5.     Market for Common Equity and Related Stockholder
               Matters                                           -2-

   Item 6.     Management's Discussion and Analysis or Plan of
               Operation                                         -3-

   Item 7.     Financial Statements                              -4-

   Item 8.     Changes in and Disagreements with Accountants on
               Accounting and Financial Disclosure               -5-

   Item 8A.    Controls and Procedures                           -6-

   Item 8B     Other Information                                 -6-

PART III                                                         -6-
   Item 9.     Directors, Executive Officers, Promoters and
               Control Persons; Compliance With Section 16(a)
               of the Exchange Act                               -6-

   Item 10.    Executive Compensation                            -8-

   Item 11.    Security Ownership of Certain Beneficial Owners
               And Management and Related Stockholder Matters    -9-

   Item 12.    Certain Relationships and Related Transactions   -11-

   Item 13.    Exhibits                                         -11-

   Item 14.    Principal Accountant Fees and Services           -11-

SIGNATURES                                                      -13-

EXHIBIT INDEX                                                   -14-

</TABLE>
                                     -i-


<PAGE>
                                  PART I

ITEM 1. DESCRIPTION OF BUSINESS

BACKGROUND

     Orthodontix, Inc. (the "Company") was formed as Embassy Acquisition
Corp., a Florida corporation, in November 1995 for the purpose of effecting a
merger with an operating business.  In April 1998, the Company merged with an
orthodontic practice management company and acquired certain assets and
assumed certain liabilities of 26 orthodontic practices (the "Practices") in
exchange for shares of the Company's Common Stock and the entering into of
practice management service agreements with the Practices (the "Merger").
Upon completing the Merger, the Company changed its name to Orthodontix, Inc.
and began managing the business aspects of the Practices, including billing,
collections, cash management and payroll processing, in exchange for a
management fee.  By November 1999, the Company had ceased providing practice
management services.  By May 2001, the Company had terminated its affiliation
with all the Practices.  The Company sold certain Practice assets back to the
Practices and assumed certain liabilities.  During the years ended December
31, 2000 and 2001, the Company terminated its affiliation with all of the
Practices and recorded the sales of all the Practice assets and the shares of
Common Stock returned in connection with the transactions.  In addition, the
Company recorded the Common Stock returned in connection with the
resignations of management.  Such transactions are reflected in the Company's
Annual Reports on Form 10-KSB for the years then ended.  See "MANAGEMENT'S
DISCUSSION AND ANALYSIS AND PLAN OF OPERATION" at page 3 for a further
discussion.

FUTURE PLANS

     The Company intends to effect a merger, acquisition or other business
combination with an operating company by using a combination of Common Stock,
cash on hand, or other funding sources that the Company reasonably believes
are available.  Management devotes substantially all of its time to
identifying potential merger or acquisition candidates.  The Company is
searching for an established business, principally in South Florida, and the
Company has evaluated companies operating in selected industries, including
business services, health care, manufacturing, distribution, aviation,
pharmaceutical and banking.

     Although the Company believes that it will be successful in consummating
a business combination with an operating company, there can be no assurances
that the Company will enter into such a transaction in the near future or on
terms favorable to the Company, or that other funding sources will be
available.

EMPLOYEES

     Except for Glenn L. Halpryn, the Company's Chief Executive Officer, the
Company currently has no full-time or part-time employees. The Company's
Acting Chief Financial Officer, Alan Jay Weisberg, is compensated by the
Company on a project basis through the accounting firm of Weisberg Brause &
Co., a firm in which Mr. Weisberg is a shareholder.

                                      1
<PAGE>

ITEM 2. DESCRIPTION OF PROPERTY

     The Company currently maintains, at no cost to the Company, its
executive offices in approximately 500 square feet of office space located at
1428 Brickell Avenue, Suite 105, Miami, Florida 33131.  Such office space
represents a portion of the corporate offices of Transworld Investment
Corporation ("TIC"), a company in which Glenn L. Halpryn and Noah Silver,
directors and executive officers of the Company, are officers and/or
directors.

ITEM 3. LEGAL PROCEEDINGS

     None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     During the fourth quarter of the year ended December 31, 2005, no
matters were submitted to a vote of security holders of the Company.

                                  PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

     The Common Stock of the Company is quoted for trading in the over-the-
counter electronic bulletin board market (the "OTC Bulletin Board") under the
symbol "OTIX."  The following table shows the reported high and low bid
quotations for the Common Stock obtained from the OTC Bulletin Board for the
periods indicated.  The high and low bid prices for such periods are
interdealer prices, without retail mark-up, mark-down or commissions and may
not represent actual transactions.

<TABLE>
<CAPTION>
OTC Bulletin Board                          Low Bid          High Bid
----------------------------------        -------------    ------------
<S>                                           <C>               <C>
2005
   First Quarter                              $.16             $ .20
   Second Quarter                             $.16             $ .20
   Third Quarter                              $.11             $ .21
   Fourth Quarter                             $.20             $5.50

2004
   First Quarter                              $.20             $ .20
   Second Quarter                             $.20             $ .30
   Third Quarter                              $.20             $ .30
   Fourth Quarter                             $.20             $ .20
</TABLE>





                                      2


<PAGE>
     The Company has approximately 57 stockholders of record as of March 27,
2006, inclusive of those brokerage firms and/or clearinghouses holding the
Company's shares of Common Stock for their clientele (with each such
brokerage house and/or clearinghouse being considered as one holder).

     The Company has not paid or declared any dividends upon its Common Stock
since its inception and does not contemplate or anticipate paying any
dividends upon its Common Stock in the foreseeable future.

ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION

     The following discussion with regard to the Company's financial
condition and results contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements are based on current plans and expectations of the Company and
involve substantial risks and uncertainties that could cause actual future
activities and results of operations to be materially different from those
set forth in the forward-looking statements.

     Important factors that could cause actual results to differ from the
Company's plans and expectations include, among others, the Company's
inability to consummate an acquisition of an operating business on terms
favorable to the Company or, in the event that the Company does consummate
the transaction contemplated, the Company's ability to successfully manage
and operate the combined business.

     The discussion of the Company's financial condition and plan of
operation, should be read in conjunction with the Company's Financial
Statements and Notes thereto included elsewhere in this Report.

FINANCIAL RESULTS FOR THE YEARS ENDED DECEMBER 31, 2005 AND DECEMBER 31,
2004.

     REVENUES.  The Company ceased providing orthodontics practice management
services to the Practices as of November 1999.  No management service fee
revenue or other operating revenue was recorded by the Company during the
years ended December 31, 2005 and 2004.  The Company does not expect to
generate operating revenue until such time as the Company consummates a
business combination with an operating company.

     GENERAL AND ADMINISTRATIVE EXPENSES.  General and administrative
expenses were approximately $93,300 and $165,600 for the years ended December
31, 2005 and 2004, respectively.  During 2004 and 2005, such expenses
consisted primarily of insurance, and legal and accounting costs.

     The Company anticipates that its general and administrative expenses
will remain low until such time as the Company effects a merger or other
business combination with an operating company.







                                      3
<PAGE>
     INTEREST INCOME.  Interest income of approximately $14,200 and $5,500
for the years ended December 31, 2005 and 2004, respectively, represents
interest earned on excess cash balances invested primarily in short-term
money market accounts.  The increase in interest income for year 2005 is
primarily attributable to higher market rates of interest combined with the
Company's having more cash invested at year end.

     NET LOSS. For the years ended December 31, 2005 and 2004, the Company
recorded a net loss of approximately $75,000 and $160,000, respectively, or
$0.02 and $0.05 per share, respectively.

     The Company does not expect to generate net income, if at all, until
such time as it effects a business combination with an operating company.
However, in the event that the Company does consummate a merger or an
acquisition of an operating company, there can be no assurances that the
combined operation will operate profitably.

LIQUIDITY AND CAPITAL RESOURCES

     As of December 31, 2005, the Company had cash and cash equivalents of
approximately $985,000, no investments, and total liabilities of
approximately $73,000.  The Company's cash is currently invested in money
market accounts and certificates of deposit.  The Company continues to
anticipate that the primary uses of working capital will include general and
administrative expenses and costs associated with seeking to locate and
consummate a business combination.  The Company believes that its operating
funds will be sufficient for its cash expenses for at least the next twelve
months.  At December 31, 2005, the Company had no ongoing contractual
commitments or off-balance sheet arrangements.

PLAN OF OPERATION

     Management of the Company intends to continue devoting substantially all
of its time to identifying merger or acquisition candidates, targeting
established businesses in selected industries, including business services,
health care, manufacturing, distribution, aviation, pharmaceutical and
banking.  In the event that the Company locates an acceptable operating
business, the Company intends to effect the transaction by using a
combination of its Common Stock, cash on hand, or other funding sources that
the Company reasonably believes are available.  However, there can be no
assurances that the Company will be able to consummate a merger or
acquisition of an operating business on terms favorable to the Company, or
that other funding sources will be available.

ITEM 7. FINANCIAL STATEMENTS

     The financial statements included herein, commencing at page F-1, have
been prepared in accordance with the requirements of Regulation S-B.







                                      4
<PAGE>
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

     On November 12, 2004, PricewaterhouseCoopers LLP ("PwC") resigned as the
Independent Registered Public Accounting firm for Orthodontix, Inc. (the
"Company").

     Except as disclosed in the next sentence of this paragraph, the reports
of PwC on the Company's financial statements for the year ended December 31,
2003 did not contain an adverse opinion or disclaimer of opinion and were not
qualified or modified as to uncertainty, audit scope or accounting principle.
As discussed in Note 1 to the Company's financial statements as of and for
the year ended December 31, 2003, the Company terminated its affiliation with
all of its founding practices and intends to effect a merger, acquisition or
other business combination with an operating company utilizing any
combination of its common stock, cash on hand or other funding sources.

     During the year ended December 31, 2003, and through November 12, 2004,
there were no disagreements with PwC on any matter of accounting principles
or practices, financial statement disclosure, or auditing scope or procedure,
which disagreements, if not resolved to the satisfaction of PwC, would have
caused PwC to make reference thereto in their reports on the financial
statements for such years.

     During the year ended December 31, 2003, and through November 12, 2004,
there were no reportable events (as defined in Item 304(a)(1)(v) of
Regulation S-K).

     The Company engaged Salberg & Co. on February 2, 2005.  The Company's
Board of Directors approved the decision to retain Salberg & Co.  The Company
authorized PwC to respond fully to the inquiries of Salberg & Co.

     On September 29, 2005, the Company dismissed Salberg & Company, P.A. and
engaged Sherb and Company, LLP as the Company's principal accountant to audit
the Company's financial statements.

     The reports of Salberg & Company, P.A. for the fiscal year ended
December 31, 2004 did not contain an adverse opinion or disclaimer of opinion
and were not modified as to uncertainty, audit scope, or accounting
principles.

     The Company's Board of Directors approved the decision to change
accountants.

     There were no disagreements with Salberg & Company, P.A. on any matter
of accounting principles or practices, financial statement disclosure, or
auditing scope or procedure, which, if not resolved to the satisfaction of
Salberg & Company, P.A. would have caused Salberg & Company, P.A. to make
reference to the subject matter of the disagreement in connection with its
report.





                                      5
<PAGE>

ITEM 8A. CONTROLS AND PROCEDURES

     The Company's management concluded an evaluation, under the supervision
and with the participation of the Company's Chief Executive Officer and Chief
Financial Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures as of December 31, 2005.  Based
on this evaluation, the Chief Executive Officer and Chief Financial Officer
concluded that the Company's disclosure controls and procedures are effective
as of December 31, 2005.

     In addition, the Chief Executive Officer and Chief Financial Officer
have determined that there have been no changes in the Company's internal
control over financial reporting during the period covered by this report
that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.

ITEM 8B. OTHER INFORMATION

     All information required to be disclosed on Form 8-K during the fourth
quarter of 2005 was disclosed in the Form 8-K filed on December 6, 2005.

                                 PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

DIRECTORS AND EXECUTIVE OFFICERS

     The current directors and executive officers of the Company are as
follows:
<TABLE>
<CAPTION>
NAME                      AGE       POSITION
----                      ---       --------
<S>                        <C>      <C>
Glenn L. Halpryn           45       Chairman of the Board of
                                    Directors, Chief Executive
                                    Officer, President and
                                    Secretary

Alan Jay Weisberg          60       Acting Chief Financial and
                                    Accounting Officer, Director

Noah M. Silver             47       Director
</TABLE>

     Glenn L. Halpryn has been the Company's Chief Executive Officer since
May 2001 and Chairman of the Board of Directors, President and Secretary of
the Company since April 2001.  Mr. Halpryn has been a member of the Board of
Directors since its inception and served a previous term as President of the
Company from its inception through the closing of the Merger.  Mr. Halpryn is
also Chief Executive Officer and a director of Transworld Investment
Corporation ("TIC"), serving in such capacity since June 2001.  From 1984 to

                                      6
<PAGE>
June 2001, Mr. Halpryn served as Vice President/Treasurer of TIC.  From 1999,
Mr. Halpryn also served as Vice President of Ivenco, Inc. ("Ivenco") until
Ivenco's merger into TIC in June 2001.  In addition, since 1984, Mr. Halpryn
has been engaged in real estate investment and development activities,
including the management, finance and leasing of commercial real estate.
From April 1988 through June 1998, Mr. Halpryn was Vice Chairman of Central
Bank, a Florida state-chartered bank.  Since June 1987, Mr. Halpryn has been
the President of and beneficial holder of stock of United Security
Corporation ("United Security"), a broker-dealer registered with the NASD.
From June 1992 through May 1994, Mr. Halpryn served as the Vice President,
Secretary-Treasurer of Frost Hanna Halpryn Capital Group, Inc., a "blank
check" company whose business combination was effected in May 1994 with
Sterling Healthcare Group, Inc.  From June 1995 through October 1996, Mr.
Halpryn served as a member of the Board of Directors of Sterling Healthcare
Group, Inc.  Since October 2002, Mr. Halpryn has been a director of Ivax
Diagnostics, Inc., a publicly held corporation, and is a member of its audit
committee.

     Alan Jay Weisberg has been the Company's Acting Chief Financial Officer
since September 1999 and a member of the Board of Directors and Treasurer of
the Company since April 2001. Since July 1986, Mr. Weisberg has been a
stockholder in the accounting firm of Weisberg Brause & Co., Boca Raton,
Florida.  Mr. Weisberg has been the principal financial officer of United
Security since June 1987.

     Noah M. Silver has been a member of the Company's Board of Directors
since April 2001 and was a consultant to the Company during 1999.  Mr. Silver
has been the Chief Financial Officer of TIC since June 2001, a firm in which
Mr. Halpryn is the Chief Executive Officer and a director.  From March 2000,
Mr. Silver served as the Chief Financial Officer of Ivenco, serving in such
capacity until Ivenco's merger into TIC in June 2001.  From January 1997
through February 1999, Mr. Silver was the President of Dryclean USA, Florida
Division, and Dryclean USA Franchise Company.  From April 1995 through
December 1996, Mr. Silver was the Florida Division Controller and Vice
President of Dryclean USA, the parent company of Dryclean USA, Florida
Division.  Mr. Silver is a Certified Public Accountant and a Certified
Management Accountant and has earned a Master of Accounting Degree.

AUDIT COMMITTEE FINANCIAL EXPERTS

     The Board of Directors has determined that the Company has two audit
committee financial experts serving on its audit committee--Noah M. Silver
and Alan Jay Weisberg.  Only Mr. Silver is independent.

COMPLIANCE WITH SECTION 16(a)

     To the Company's knowledge, based solely upon the Company's review of
Forms 3, 4 and 5 furnished to the Company, for the year ended December 31,
2005, no person who was a director, officer or beneficial owner of more than
ten percent of the Company's outstanding Common Stock or any other person
subject to Section 16 of the Securities Exchange Act of 1934 (the "Exchange
Act") failed to file on a timely basis, reports required by Section 16(a) of
the Exchange Act.


                                      7
<PAGE>
CODE OF ETHICS

     The Company adopted a code of ethics that applies to all officers,
directors and employees of the Company.  Any person may obtain a copy of the
code of ethics at no charge from the Company by writing to the Company at
1428 Brickell Avenue, Suite 105, Miami, Florida 33131.

ITEM 10. EXECUTIVE COMPENSATION

DIRECTOR COMPENSATION

     During the year ended December 31, 2005, each director of the Company
(employee and non-employee directors alike) received $400 for each Board
meeting attended as well as reimbursement for any reasonable business
expenses incurred by the director in connection with his activities on behalf
of the Company.  During 2005, the Company held one meeting of the Board of
Directors.  In addition, directors are entitled to receive stock options
under the 1997 Orthodontix, Inc. Stock Option Plan.  No such stock options
were granted to directors during the year ended December 31, 2005.

EXECUTIVE COMPENSATION

     No executive officer of the Company was compensated more than $100,000
during the year ended December 31, 2005. The following table sets forth all
the compensation earned by Glenn L. Halpryn, who has been the Company's Chief
Executive Officer since May 2001.
<TABLE>
SUMMARY COMPENSATION TABLE
<CAPTION>
                      Annual Compensation               Long Term Compensation Awards
                    -----------------------     -------------------------------------------
Name and                                                           Securities
Principal                                       Other Annual       Underlying     All Other
Position            Year     Salary   Bonus     Compensation       Options        Compensation
----------------------------------------------------------------------------------------------
<S>             <C>   <C>     <C>     <C>                <C>        <C>
Glenn Halpryn,      2005   $     0   $ 0       $  0                    0             $400
Chief Executive     2004   $41,700   $ 0       $  0                    0             $900
Officer(1)           2003   $50,000   $ 0       $  0                    0             $300
<FN>
    (1)  In October 2004, Mr. Halpryn waived his salary for the balance of
2004.  During 2005 Mr. Halpryn received no salary from the Company.
</FN>
</TABLE>

STOCK OPTION GRANTS IN 2005

     No options to purchase shares of the Company's Common Stock were granted
to any executive officer during the year ended December 31, 2005. The
following table sets forth certain summary information concerning grants of
options to purchase shares of the Company's Common Stock during the year
ended December 31, 2005:




                                       8
<PAGE>
<TABLE>
<CAPTION>
                  Number of Securities  % of Total Options     Exercise/
                   Underlying Options    Granted to Employees   Base Price/   Expiration
Name               Granted               in Fiscal Year         Share         Date
----------------------------------------------------------------------------------------
<S>                 <C>              <C>             <C>       <C>
Glenn Halpryn            N/A                   ---                ---          ---
</TABLE>

STOCK OPTION EXERCISES IN 2005
AND YEAR-END OPTION VALUES

     No options to purchase shares of the Common Stock of the Company were
exercised by any executive officer of the Company during the year ended
December 31, 2005 and at December 31, 2005, there were no unexercised options
to purchase the Company's Common Stock held by any executive officer of the
Company.  The following table sets forth certain summary information
concerning exercised and unexercised options to purchase shares of the
Company's Common Stock as of December 31, 2005:

<TABLE>
<CAPTION>

                   Shares                                              Value of Unexercisable In-
                   Acquired                 Number of Unexercised      the-money Options at FY-
                   on         Value         Options at FY-end          end Exercisable /
Name               Exercise   Realized   Exercisable/Unexercisable     Unexercisable
-------------------------------------------------------------------------------------------------
<S>              <C>      <C>            <C>                   <C>

Glenn L. Halpryn     ---         N/A               0/0                         $0/$0
</TABLE>

EMPLOYMENT CONTRACTS, TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL
ARRANGEMENTS

     Neither Mr. Halpryn, the Company's Chief Executive Officer, nor any
other executive officer of the Company, has an employment agreement with the
Company.

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
         AND RELATED STOCKHOLDER MATTERS

     The following table sets forth information known to the Company with
respect to the beneficial ownership of its Common Stock as of March 27, 2006
by (i) each stockholder known by the Company to own beneficially more than 5%
of the outstanding Common Stock, (ii) each named executive officer of the
Company, (iii) each director of the Company, and (iv) all directors and
executive officers as a group. As of March 27, 2006, there were 5,830,856
shares of Common Stock outstanding.






                                       9
<PAGE>
PRINCIPAL SHAREHOLDERS
<TABLE>
<CAPTION>

Name and Address               Shares of Common Stock      Percent
of Beneficial Owner            Beneficially Owned(1)        Owned
------------------------------------------------------------------
<S>                                   <C>                  <C>
Phillip Frost, M.D.                   2,965,428(2)          51.0%
4400 Biscayne Blvd.
Miami, FL 33137

Stephen Grussmark                       450,000(3)          7.7%
7400 North Kendall Drive Suite 704
Miami, FL  33156

Glenn L. Halpryn                        380,100            6.5%
1428 Brickell Avenue, Suite 105
Miami, FL  33131

Alan Jay Weisberg                         4,201            0.07%
1428 Brickell Avenue, Suite 105
Miami, FL  33131

Noah Silver                                   0            0%
1428 Brickell Avenue, Suite 105
Miami, FL  33131

All Officers and                        384,301            6.6%
Directors as a Group(2)

Total Shares Outstanding
as of March 27, 2006                  5,830,856
<FN>
(1)  Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission. In computing the number of shares
beneficially owned by a person and the percentage ownership of that person,
shares of Common Stock subject to options or warrants held by that person
that are currently exercisable or will become exercisable within 60 days
after March 27, 2006 are deemed outstanding, while such shares are not deemed
outstanding for purposes of computing percentage ownership of any other
person. Unless otherwise indicated in the footnotes below, the persons and
entities named in the table have sole voting and investment power with
respect to all shares beneficially owned, subject to community property laws
where applicable.

(2)  Represents shares of Common Stock held by Frost Gamma Investments Trust,
of which Frost Gamma Limited Partnership is the sole and exclusive
beneficiary.  Dr. Phillip Frost is the sole limited partner of Frost Gamma,
L.P.  The general partner of Frost Gamma, L.P. is Frost Gamma, Inc. and the
sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation.  Dr. Frost
is also the sole shareholder of Frost-Nevada Corporation.



                                     10
<PAGE>

(3)  Represents shares of Common Stock held in various trusts for which
either Dr. Grussmark or his wife is the sole trustee and the beneficiaries of
which are Dr. Grussmark, his wife or his children.
</FN>
</TABLE>

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

     Alan Jay Weisberg, CPA, the Company's Acting Chief Financial Officer
since September 1999 and a member of the Company's Board of Directors and
Treasurer since April 2001, is a shareholder of Weisberg Brause, which firm
was paid $5,800 and $4,850 during the years ended December 31, 2005 and 2004,
respectively.

     Since June 2001, the Company has utilized as its principal office, a
portion of the corporate offices of TIC, a company in which Messrs. Halpryn
and Silver are officers and directors.  The Company occupies such space free
of rent.

ITEM 13. EXHIBITS

         Documents filed as part of this report

         1. Financial Statements

            See page F-1.

         2. Exhibits:

            See Exhibit Index. The Exhibits listed in the accompanying
Exhibit Index are filed or incorporated by reference as part of this report.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

AUDIT FEES

     Sherb and Company, LLP billed the Company $3,500 for review of financial
statements included in the Company's Form 10-QSB for the quarter ended
September 30, 2005 and expects to bill the Company $8,500 for the audit of
the Company's annual financial statements for the year ended December 31,
2005.  Salberg & Co., P.A., the former Independent Registered Public
Accounting Firm for the Company, billed the Company $8,600 in 2005 for the
audit of the Company's annual financial statements for the year ended
December 31, 2004 and $7,000 for review of financial statements included in
the Company's Forms 10-QSB for the quarters ended March 31 and June 30, 2005.
PricewaterhouseCoopers LLP, the principal accountant for the Company during
2004, billed the Company $27,800 in 2004, for professional services rendered
for the audit of the Company's annual financial statements and review of
financial statements included in the Company's Forms 10-QSB.





                                      11
<PAGE>

AUDIT-RELATED FEES

     The Company paid no fees to its principal accountant except the audit
fees reported above for 2004 and 2005.

TAX FEES

     The Company paid no fees to its principal accountant for tax compliance,
tax advice or tax planning during the past two fiscal years.  The Company
paid $1,235 in 2005 and $1,235 in 2004 to another accounting firm that
prepared the Company's tax returns.

ALL OTHER FEES

     The Company paid only the audit fees reported above to its principal
accountant during 2004 and 2005.

AUDIT COMMITTEE PRE-APPROVAL POLICIES

     The Audit Committee pre-approved all services performed by the Company's
principal accountant before the accountant was engaged in accordance with the
Audit Committee's procedure of requiring the details of the services to be
performed.































                                      12
<PAGE>
SIGNATURES

     In accordance with Section 13 or 15(d) of the Exchange Act, the
Registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

By: /s/ Glenn Halpryn
    ----------------------
    Glenn Halpryn, Chief Executive Officer

March 29, 2006

     In accordance with the Exchange Act, this report has been signed below
by the following persons on behalf of the Registrant in the capacities and on
the dates indicated.

By: /s/ Glenn Halpryn
    ----------------------
    Glenn Halpryn, Chairman of the Board,
       Chief Executive Officer, President, Secretary

March 29, 2006


By: /s/ Alan Jay Weisberg
    ----------------------
    Alan Jay Weisberg, Acting Chief Financial
       and Accounting Officer, Director

March 29, 2006


By: /s/ Noah Silver
    ----------------------
    Noah Silver, Director

March 29, 2006


















                                      13
<PAGE>
INDEX TO FINANCIAL STATEMENTS

<TABLE>
<CAPTION>

                                                                        Pages

<S>                                                                      <C>
Report of Independent Registered Public Accounting
   Firm                                                                  F-2

Report of Former Independent Registered Public
   Accounting Firm                                                       F-3

Balance Sheet                                                            F-4

Statements of Operations                                                 F-5

Statements of Changes in Stockholders' Equity                            F-6

Statements of Cash Flows                                                 F-7

Notes to Financial Statements                                     F-8 - F-13

</TABLE>



























                                     F-1


<PAGE>

           Report of Independent Registered Public Accounting Firm


To the Board of Directors
of Orthodontix, Inc.

We have audited the accompanying balance sheet of Orthodontix, Inc. as of
December 31, 2005 and the related statements of operations, changes in
stockholders' equity and cash flows for the year then ended.  These financial
statements are the responsibility of the Company's management.  Our
responsibility is to express an opinion on these financial statements based
on our audit.  The financial statements of Orthodontix, Inc. as of December
31, 2004, were audited by other auditors whose report dated March 16, 2005,
expressed an unqualified opinion on those statements.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement.  An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements.  An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation.  We believe that our
audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly in
all material respects, the financial position of Orthodontix, Inc. as of
December 31, 2005, and the results of their operations, changes in
stockholders' equity and cash flows for the year then ended, in conformity
with accounting principles generally accepted in the United States of
America.



Sherb and Co., LLP
Boca Raton, Florida
January 30, 2006
















                                    F-2


<PAGE>

           Report of Independent Registered Public Accounting Firm


To the Board of Directors
of Orthodontix, Inc.

We have audited the accompanying statements of operations, changes in
stockholders' equity and cash flows of Orthodontix, Inc. for the year ended
December 31, 2004.  These financial statements are the responsibility of the
Company's management.  Our responsibility is to express an opinion on these
financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement.  An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements.  An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation.  We believe that our
audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly in
all material respects, the results of operations, changes in stockholders'
equity and cash flows of Orthodontix, Inc. for the year ended December 31,
2004, in conformity with accounting principles generally accepted in the
United States of America.



SALBERG & COMPANY, P.A.
Boca Raton, Florida
March 16, 2005
















                                    F-3



<PAGE>
ORTHODONTIX, INC.
BALANCE SHEET
December 31, 2005
------------------------------------------
<TABLE>
<CAPTION>
                                                                             2005
<S>                                                                     <C>
                                        Assets
Current assets:
   Cash and cash equivalents                                            $    985,238
   Prepaid expenses                                                            2,123
                                                                        ------------
     Total current assets                                                    987,361
                                                                        ============

                            Liabilities and Stockholders' Equity
Current liabilities:
   Accrued liabilities                                                        72,930
                                                                        ------------
     Total current liabilities                                                72,930
                                                                        ------------


Stockholders' equity:
   Preferred stock, $.0001 par value, 100,000,000 shares
     authorized, no shares issued and outstanding                                -
   Common stock, $.0001 par value, 100,000,000 shares
     authorized, 5,830,856 shares issued and outstanding                         583
   Additional paid-in capital                                              4,726,530
   Accumulated deficit                                                    (3,812,682)
                                                                        ------------
     Total stockholders' equity                                              914,431
                                                                        ------------
     Total liabilities and stockholders' equity                          $   987,361
                                                                        ============
</TABLE>



See Accompanying Notes to Financial Statements.

                                                            F-4


<PAGE>
ORTHODONTIX, INC.
Statements of Operations
For the years ended December 31, 2005 and 2004
----------------------------------------------
<TABLE>
<CAPTION>

                                                                             For the years ended December 31,
                                                                            2005                          2004
<S>                                                                     <C>                        <C>
Operating Expenses:
General and administrative expenses                                     $      93,295              $     165,582
                                                                         ------------               ------------
     Total operating expenses                                                  93,295                    165,582
                                                                         ------------               ------------
     Loss from Operations                                                     (93,295)                  (165,582)
                                                                         ------------               ------------

Other income:
   Interest income                                                             14,150                      5,512
   Other income                                                                 4,214                        -
                                                                         ------------               ------------
     Total other income                                                        18,364                      5,512
                                                                         ------------               ------------
Net loss                                                                  $   (74,931)               $  (160,070)
                                                                         ============               ============

Net Loss per share--Basic and Diluted                                   $       (0.02)              $      (0.05)
                                                                         ============               ============


Weighted average number of shares outstanding
   during the year--basic and diluted                                       3,163,040                  2,915,428
                                                                         ============               ============
</TABLE>

See Accompanying Notes to Financial Statements.














                                                            F-5
<PAGE>
ORTHODONTIX, INC.
Statements of Changes in Stockholders' Equity
For the years ended December 31, 2005 and 2004
-----------------------------------------------
<TABLE>
<CAPTION>

                                                                           Additional
                                                        Common Stock        Paid-In    Accumulated
                                                     Shares      Amount     Capital      Deficit        Total
                                                   ---------  ----------  ----------- ------------   ----------
<S>                                                <C>        <C>         <C>         <C>            <C>

Balance, December 31, 2003                         2,915,428  $     292   $ 4,232,821 $(3,577,681)   $ 655,432

Net loss, 2004                                           -          -             -      (160,070)    (160,070)
                                                   ---------  ----------  ----------- ------------   ----------

Balance, December 31, 2004                         2,915,428        292     4,232,821  (3,737,751)     495,362

Stock issued for cash                              2,915,428        291       493,709         -        494,000

Net loss, 2005                                           -          -             -       (74,931)     (74,931)
                                                   ---------  ----------  ----------- ------------   ----------

Balance, December 31, 2005                         5,830,856  $     583   $ 4,726,530 $(3,812,682)   $ 914,431
                                                   =========  ==========  =========== ============   ==========


</TABLE>
See Accompanying Notes to Financial Statements.








                                                            F-6


<PAGE>
ORTHODONTIX, INC.
Statements of Cash Flows
For the years ended December 31, 2005 and 2004
-----------------------------------------------
<TABLE>
<CAPTION>
                                                      For the years ended December 31,
                                                           2005               2004
                                                      -------------       ------------
<S>                                                   <C>                 <C>
Cash flows from operating activities:
   Net loss                                           $   (74,931)        $  (160,070)
   Adjustments to reconcile net loss to net cash used
    in operating activities:
    Changes in operating assets and liabilities:
      Prepaid expenses and other current assets                 1                 294
      Accounts payable and accrued liabilities              2,455              (8,349)
                                                      -------------       ------------

        Net cash used in operating activities             (72,475)           (168,125)
                                                      -------------       ------------

Cash flows from investing activities:
   Redemption of Certificate of Deposit                       -               552,359
                                                      -------------       ------------

        Net cash provided by investing activities             -               552,359
                                                     -------------       ------------

Cash Flows from Financing Activities:
   Proceeds from issuance of common stock                 494,000                 -
                                                      -------------       ------------

       Net cash Provided by Financing Activities          494,000                 -
                                                      -------------       ------------

Net increase in cash and cash equivalents             $   421,525         $   384,234

Cash at beginning of year                                 563,713             179,479
                                                     -------------       ------------
Cash at end of year                                   $   985,238         $   563,713
                                                     =============       ============

Supplemental Disclosure of Cash Flow Information

Cash paid for:
   Income taxes                                       $       -           $       -
                                                     =============       ============
   Interest                                           $       -           $       -
                                                     =============       ============

</TABLE>

See Accompanying Notes to Financial Statements.






                                      F-7


<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

1.     Nature of Operations

       On April 16, 1998, Orthodontix, Inc. and subsidiaries ("Orthodontix"
or the "Company") consummated a merger (the "Merger") with Embassy
Acquisition Corp. ("Embassy"), a publicly held Florida corporation.
Simultaneously with the closing of the Merger, the Company acquired certain
assets and assumed certain liabilities of 26 orthodontic practices (the
"Founding Practices").

       During the year ended December 31, 1999, the Company began to
terminate its affiliation with the Founding Practices.  During the year ended
December 31, 2001, the Company terminated its affiliation with all 26
Founding Practices.

       The accompanying financial statements have been prepared on the basis
which assumes that the Company will continue to operate as a going concern
and which contemplates the realization of assets and the satisfaction of
liabilities and commitments in the normal course of business.  The Company
has generated an accumulated deficit of approximately $3.8 million at
December 31, 2005 as a result of operations and the termination of its
affiliation with the Founding Practices.  The Company incurred net losses of
approximately $75,000 and $160,000 for the years ended December 31, 2005 and
2004, respectively.  The Company also reflects net cash used in operations of
$72,475 and $168,125 for the years ended December 31, 2005 and 2004,
respectively.

       The Company currently intends to effect a merger, acquisition or other
business combination with an operating company utilizing any combination of
its common stock, cash on hand or other funding sources that the Company
believes are available. During the year ended December 31, 2005, management
has devoted substantially all of its time to identifying potential merger or
acquisition candidates.  There can be no assurances that management's efforts
to consummate a merger, acquisition or business combination with an operating
company or management's efforts to identify other funding sources will be
successful.  The Company anticipates that its current working capital is
sufficient to fund its operating expenses at their current level for at least
the next twelve months.









                                     F-8


<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

2.     Summary of Significant Accounting Policies

       Use of Estimates

       In preparing financial statements, management is required to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, disclosure of contingent assets and liabilities at the date of
the financial statements, and revenues and expenses during the periods
presented.  Actual results may differ from these estimates.

       Significant estimates during 2005 and 2004 include a 100% valuation
allowance for deferred tax assets.

       Cash and Cash Equivalents

       For the purpose of the cash flow statements, the Company considers all
highly liquid investments with original maturities of three months or less at
the time of purchase to be cash equivalents.  In 2005, the Company purchased
certificates of deposits, using funds from a money market account, and
proceeds from sale of common stock.  (See Notes 5 and 6)

       For the years ended December 31, 2005 and 2004, the Company recognized
interest income on these certificates of deposit totaling $14,150 and $5,512,
respectively.

       During 2004 the Company redeemed a certificate of deposit with the
proceeds being transferred into a money market account.

       Concentrations

       The Company maintains its cash in bank deposit accounts, which, at
times, exceed federally insured limits.  As of December 31, 2005, the Company
had deposits of $772,646 in excess of federally insured limits.  The Company
has not experienced any losses in such accounts through December 31, 2005.

       Income Taxes

       The Company accounts for income taxes under the Financial Accounting
Standards No. 109 "Accounting for Income Taxes" ("Statement 109").  Under
Statement 109, deferred tax assets and liabilities are recognized for the
future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their
respective tax bases.  Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled.  Under
Statement 109, the effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period, which includes the
enactment date.


                                     F-9
<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

       Earnings Per Share

       In accordance with Statement of Financial Accounting Standards No.
128, "Earnings per Share", basic earnings per share is computed by dividing
the net income (loss) less preferred dividends for the period by the weighted
average number of shares outstanding.  Diluted earnings per share is computed
by dividing net income (loss) less preferred dividends by the weighted
average number of shares outstanding including the effect of share
equivalents.  At December 31, 2005 and 2004, there were no common share
equivalents, which could potentially dilute future earnings per share.

       Stock Options

       The Company accounts for options granted to employees using the
intrinsic value method.  The Company has chosen not to apply the fair value
accounting rules in the statements of operations for employee stock-based
compensation but such treatment is required for non-employee stock-based
compensation.  The Company has chosen the alternative to disclose pro forma
net loss and loss per share as if the fair value accounting rules were used
for options granted to employees.

       The Company had no stock options outstanding during the years ended
December 31, 2005 and 2004.  Therefore, there was no impact of fair value
accounting rules on the Company's net loss and net loss per share--basic and
diluted for the years ended December 31, 2005 and 2004.

       Fair Value of Financial Instruments

       Statement of Financial Accounting Standards No. 107, "Disclosures
about Fair Value of Financial Instruments," requires disclosures of
information about the fair value of certain financial instruments for which
it is practicable to estimate the value.  For purpose of this disclosure, the
fair value of a financial instrument is the amount at which the instrument
could be exchanged in a current transaction between willing parties, other
than in a forced sale or liquidation

       The carrying amounts of the Company's short-term financial instruments,
including prepaids and accrued liabilities approximate fair value due to the
relatively short period to maturity for these instruments.

       New Accounting Pronouncements

       In December 2004, the FASB issued SFAS 153 "Exchanges of Non-monetary
Assets"--an amendment of APB Opinion No. 29.  This Statement amended APB
Opinion 29 to eliminate the exception for non-monetary exchanges of similar
productive assets and replaces it with a general exception for exchanges of
non-monetary assets that do not have commercial substance.  A non-exchange
has commercial substance if the future cash flows of the entity are expected
to change significantly as a result of the exchange.  The adoption of this

                                    F-10
<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

standard is not expected to have any material impact on the Company's
financial position, results of operations or cash flows.

       In December 2004, the FASB issued SFAS 123 (revised 2004) "Share-Based
Payment" ("SFAS No. 123R").  This Statement requires that the cost resulting
from all share-based transactions be recorded in the financial statements.
The Statement establishes fair value as the measurement objective in
accounting for share-based payment arrangements and requires all entities to
apply a fair-value-based measurement in accounting for share-based payment
transactions with employees.  The Statement also establishes fair value as
the measurement objective for transactions in which an entity acquires goods
or services from non-employees in share-based payment transactions.  The
Statement replaces SFAS 123 "Accounting for Stock-Based Compensation" and
supersedes APB Opinion No. 25 "Accounting for Stock Issued to Employees".
The provisions of this Statement will be effective for the Company beginning
with its fiscal year ending 2005.  The Company has adopted the provisions of
SFAS No. 123R effective January 1, 2006.

3.     Income Taxes

       There was no income tax expense for the years ended December 31, 2005
and 2004 due to the Company's net losses.

       The Company's tax expense differs from the "expected" tax expense for
the years ended December 31, 2005 and 2004, (computed by applying the Federal
Corporate tax rate of 34% to loss before taxes and 5.5% for State Corporate
taxes, the blended rate used was 37.63%), as follows:
<TABLE>
<CAPTION>

                                        2005              2004
<S>                                <C>                <C>
Computed "expected" tax expense
   (benefit)--Federal             $  (24,075)         $ (51,430)
Computed "expected" tax expense
    (benefit)--State                  (4,122)            (8,804)
Change in valuation allowance         28,197             60,234
                                   -----------        -----------
   Total                           $      -             $    -
                                   ===========        ===========
</TABLE>









                                     F-11
<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

       The effects of temporary differences that gave rise to significant
portions of deferred tax assets at December 31, 2005 are as follows:
<TABLE>
<S>                                  <C>

Deferred tax assets:

   Net operating loss carryforward  (1,088,358)
                                    -----------
   Total gross deferred tax assets  $1,088,358
   Less valuation allowance         (1,088,358)
                                    -----------
   Net deferred tax assets          $      -
                                    ===========
</TABLE>

       The Company has a net operating loss carryforward of approximately
$2,892,000 available to offset future taxable income expiring 2025.

       The valuation allowance at December 31, 2004 was $1,065,251.  The net
change in valuation allowance during the year ended December 31, 2005 was an
increase of $23,107.

       There was an additional $5,090 not included as part of the valuation
allowance as it represented the reversal of a current period temporary
difference.

       Usage of the net operating losses may be limited under Internal
Revenue code section 382 due to any changes in ownership.

4.     Stock Option Plan

       The Company adopted a stock option plan (the "Option Plan") that
provides for granting up to 500,000 shares of common stock by November 2007.
The Option Plan provides for the issuance of incentive stock options and non-
qualified stock options.  Under the Option Plan, options may be granted at
not less than the fair market value of the stock on the date of the grant.
The term of each option generally may not exceed ten years.

       There were no options outstanding at December 31, 2005 and 2004.

5.     Stockholders' Equity

       On November 30, 2005, the Company sold 2,915,428 shares of common
stock to an existing shareholder for $494,000.  As a result of the sale,
majority control of the Company was obtained by a previously unrelated third
party.  All funds were deposited into an interest bearing certificate of
deposit.  (See Note 6)


                                     F-12
<PAGE>
ORTHODONTIX, INC.
Notes to Financial Statements
December 31, 2005
------------------------------------------

6.     Related Party Transactions

       On November 30, 2005, the Company sold 2,915,428 share of common stock
to an existing shareholder for $494,000.  (See Note 5)

       During the years ended December 31, 2005 and 2004, the Company paid
accounting fees and directors fees to its CFO.  Additionally, salary and
directors fees were paid to the Company's President and CEO.  The following is
a summary of these payments.

<TABLE>
<CAPTION>

                                              2005             2004
<S>                                      <C>             <C>
   Accounting Fees--CFO                  $   5,800       $    4,850
   Salary--President and CEO                   -             41,667
   Directors Fees--President and CEO           400              900
   Directors Fees--CFO                         400            1,400
</TABLE>

       All amounts paid in 2005 and 2004, respectively, were charged to the
statement of operations.  At December 31, 2005, there are no outstanding
amounts due.


























                                     F-13
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
      Exhibit
      Number       Exhibit Description
      ------       -------------------
<S>   <C>            <C>
      2.1*         Agreement and Plan of Merger and Reorganization, dated
                   October 30, 1997, between Embassy Acquisition Corp.
                   (now known as Orthodontix, Inc. (the "Company")) and
                   Orthodontix, Inc. (now known as Orthodontix Subsidiary,
                   Inc.).

      3.1*         Amended and Restated Articles of Incorporation of the
                   Company.

      3.2*         Bylaws of the Company as amended.

      4.1*         Form of certificate representing shares of Common Stock
                   of the Company.

     10.1*         1997 Orthodontix, Inc. Stock Option Plan.

     10.2*         Form of Administrative Services Agreement of the Company.

     10.3*         Forms of Services Agreement of the Company.

     10.4*         Form of Agreement and Plan of Reorganization of the
                   Company.

     10.5*         Forms of Lock-Up Agreement.

     14.1**        Code of Ethics

     31.1          Certification of Chief Executive Officer pursuant to
                   Rule 13a-14(a) as adopted pursuant to Section 302 of
                   the Sarbanes-Oxley Act of 2002

     31.2          Certification of Chief Financial Officer pursuant to
                   Rule 13a-14(a) as adopted pursuant to Section 302 of
                   the Sarbanes-Oxley Act of 2002

     32            18 U.S.C. Section 1350, as adopted pursuant to Section 906
                   of the Sarbanes-Oxley Act of 2002, Certification of Chief
                   Executive Officer and Chief Financial Officer

---------------------------
<FN>
*  Incorporated by reference to the Company's Registration Statement on Form
S-4 declared effective on March 26, 1998 by the Securities and Exchange
Commission, SEC File No. 333-48677.
**Incorporated by reference to the Company's Annual Report on Form 10-KSB for
the year ended December 31, 2003.
</FN>
</TABLE>
                                      14
<PAGE>
                                                              Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER

     I, Glenn L. Halpryn, certify that:

     1.  I have reviewed this report on Form 10-KSB of Orthodontix, Inc.;
     2.  Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this report;
     3.  Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;
     4.  The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
     a)  designed such disclosure controls and procedures to ensure that
material information relating to the registrant is made known to us by others
within those entities, particularly during the period in which this annual
report is being prepared;
     b)  evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on our evaluation;
     5.  The registrant's other certifying officers and I have disclosed,
based on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the
equivalent functions):
     a)  all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and
     b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls.


Dated:  March 29, 2006           By:   /s/ Glenn L. Halpryn
                                    ---------------------------------------
                                    Glenn L. Halpryn
                                    Chief Executive Officer













                                      15
<PAGE>
                                                              Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER

     I, Alan Jay Weisberg, certify that:

     1.  I have reviewed this report on Form 10-KSB of Orthodontix, Inc.;
     2.  Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this report;
     3.  Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;
     4.  The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
     a)  designed such disclosure controls and procedures to ensure that
material information relating to the registrant is made known to us by others
within those entities, particularly during the period in which this annual
report is being prepared;
     b)  evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on our evaluation;
     5.  The registrant's other certifying officers and I have disclosed,
based on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the
equivalent functions):
     a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and
     b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls.


Dated:  March 29, 2006           By:   /s/ Alan Jay Weisberg
                                    ---------------------------------------
                                    Alan Jay Weisberg
                                    Acting Chief Financial Officer













                                      16
<PAGE>
                                                                Exhibit 32
CERTIFICATION PURSUANT TO RULE 13a-14(b) AND SECTION 906 OF THE SARBANES-
OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, TITLE 18, UNITED
STATES CODE)

     In connection with the Annual Report on Form 10-KSB of Orthodontix, Inc.
for the period ended December 31, 2005 as filed with the Securities and
Exchange Commission (the "Report"), we, Glenn L. Halpryn, Chief Executive
Officer of Orthodontix, Inc., and Alan Jay Weisberg, Acting Chief Financial
Officer of Orthodontix, Inc., hereby certify pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

     1.  The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2.  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
Orthodontix, Inc.




Dated:  March 29, 2006         By:   /s/ Glenn L. Halpryn
                                    ---------------------------------------
                                    Glenn L. Halpryn
                                    Chief Executive Officer


Dated:  March 29, 2006         By:   /s/ Alan Jay Weisberg
                                    ---------------------------------------
                                    Alan Jay Weisberg
                                    Acting Chief Financial Officer






















                                      17